Cargando…
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926428/ https://www.ncbi.nlm.nih.gov/pubmed/35446373 http://dx.doi.org/10.1182/blood.2022015470 |
| _version_ | 1784670234173505536 |
|---|---|
| author | Moulis, Guillaume Crickx, Etienne Thomas, Laure Massy, Nathalie Mahévas, Matthieu Valnet-Rabier, Marie-Blanche Atzenhoffer, Marina Michel, Marc Godeau, Bertrand Bagheri, Haleh Salvo, Francesco |
| author_facet | Moulis, Guillaume Crickx, Etienne Thomas, Laure Massy, Nathalie Mahévas, Matthieu Valnet-Rabier, Marie-Blanche Atzenhoffer, Marina Michel, Marc Godeau, Bertrand Bagheri, Haleh Salvo, Francesco |
| author_sort | Moulis, Guillaume |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8926428 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89264282022-03-17 De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring Moulis, Guillaume Crickx, Etienne Thomas, Laure Massy, Nathalie Mahévas, Matthieu Valnet-Rabier, Marie-Blanche Atzenhoffer, Marina Michel, Marc Godeau, Bertrand Bagheri, Haleh Salvo, Francesco Blood Letters to Blood American Society of Hematology 2022-04-21 /pmc/articles/PMC8926428/ /pubmed/35446373 http://dx.doi.org/10.1182/blood.2022015470 Text en © 2022 by The American Society of Hematology |
| spellingShingle | Letters to Blood Moulis, Guillaume Crickx, Etienne Thomas, Laure Massy, Nathalie Mahévas, Matthieu Valnet-Rabier, Marie-Blanche Atzenhoffer, Marina Michel, Marc Godeau, Bertrand Bagheri, Haleh Salvo, Francesco De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring |
| title | De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring |
| title_full | De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring |
| title_fullStr | De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring |
| title_full_unstemmed | De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring |
| title_short | De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring |
| title_sort | de novo and relapsed immune thrombocytopenia after covid-19 vaccines: results of french safety monitoring |
| topic | Letters to Blood |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926428/ https://www.ncbi.nlm.nih.gov/pubmed/35446373 http://dx.doi.org/10.1182/blood.2022015470 |
| work_keys_str_mv | AT moulisguillaume denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT crickxetienne denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT thomaslaure denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT massynathalie denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT mahevasmatthieu denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT valnetrabiermarieblanche denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT atzenhoffermarina denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT michelmarc denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT godeaubertrand denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT bagherihaleh denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT salvofrancesco denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring AT denovoandrelapsedimmunethrombocytopeniaaftercovid19vaccinesresultsoffrenchsafetymonitoring |